Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
I consider myself privileged to be part of the team.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Everyone pulling together when the pressure mounts.
Che cosa ti rende più felice sul posto di lavoro?
Seeing new effective drugs coming to market.
Quali sono alcune delle cose migliori della tuo team?
They are all highly competent people driven by doing good.
Cosa ti piace di più del team di leadership?
KPTI is a company that is always striving to get better.
Other Employee Reviews for Karyopharm Therapeutics
×